Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 5
1992 2
1993 5
1994 7
1995 3
1996 3
1998 3
1999 3
2000 2
2001 3
2002 3
2003 3
2004 1
2005 3
2006 3
2009 3
2010 1
2011 3
2012 5
2014 3
2015 4
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11731667

67 results
Results by year
Filters applied: . Clear all
Page 1
Caution about trial methodology and statistics.
Degraeuwe PL, Nieman FH. Degraeuwe PL, et al. Pediatrics. 2001 Dec;108(6):1383-4. doi: 10.1542/peds.108.6.1383-a. Pediatrics. 2001. PMID: 11731667 No abstract available.
A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K, Yaramiş A, Haspolat K, Taş MA, Günbey S, Derman O. Bilgin K, et al. Pediatrics. 2001 Jan;107(1):36-41. doi: 10.1542/peds.107.1.36. Pediatrics. 2001. PMID: 11134431 Clinical Trial.
What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit?
La Gamma EF, De Castro MH. La Gamma EF, et al. Acta Paediatr Suppl. 2002;91(438):109-16. doi: 10.1111/j.1651-2227.2002.tb02914.x. Acta Paediatr Suppl. 2002. PMID: 12477273 Review.
Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G, Walia M, Bala H, Singh S. Gathwala G, et al. J Trop Pediatr. 2012 Feb;58(1):12-8. doi: 10.1093/tropej/fmr012. Epub 2011 Feb 4. J Trop Pediatr. 2012. PMID: 21296862 Clinical Trial.
Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
Carr R, Brocklehurst P, Doré CJ, Modi N. Carr R, et al. Lancet. 2009 Jan 17;373(9659):226-33. doi: 10.1016/S0140-6736(09)60071-4. Lancet. 2009. PMID: 19150703 Clinical Trial.
Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia.
Khan TH, Shahidullah M, Mannan MA, Nahar N. Khan TH, et al. Mymensingh Med J. 2012 Jul;21(3):469-74. Mymensingh Med J. 2012. PMID: 22828545
Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
Castagnola E, Dufour C. Castagnola E, et al. Early Hum Dev. 2014 Sep;90 Suppl 2:S15-7. doi: 10.1016/S0378-3782(14)50005-9. Early Hum Dev. 2014. PMID: 25220119 Review.
Sepsis in babies: should we stimulate the phagocytes?
Shann F. Shann F. Lancet. 2009 Jan 17;373(9659):188-90. doi: 10.1016/S0140-6736(09)60052-0. Lancet. 2009. PMID: 19150690 No abstract available.
Neutrophil-releasing activity of recombinant human granulocyte-macrophage colony stimulating factor in myelokathexis.
Bohinjec J, Andoljsek D. Bohinjec J, et al. Br J Haematol. 1992 Sep;82(1):169-70. doi: 10.1111/j.1365-2141.1992.tb04609.x. Br J Haematol. 1992. PMID: 1419790 No abstract available.
Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
Mori PG, Pasino M, Dufour C, Boeri E, Molinari AC. Mori PG, et al. Blood. 1994 Nov 1;84(9):3244-5. Blood. 1994. PMID: 7524771 No abstract available.
67 results
Jump to page
Feedback